Are you above the legal age to view this content in your province/state?

Home / Industry News / Most wholesale cultivators competing on cannabis quality

Most wholesale cultivators competing on cannabis quality

Most wholesale cultivators competing on cannabis quality

U.S, July 17, 2019 (MARIJUANA BUSNESS DAILY)- Many wholesale cannabis growers choose to compete on quality, even while market forces favor growers who can reliably supply low-cost cannabis.

Nearly half of U.S. cultivators are attempting to make high-quality flower their key differentiator, according to the recently released 2019 Marijuana Business Factbook.

But with flower sales on the decline, the market likely will prove unable to sustain that proportion of growers competing on those grounds alone.
In the extract market, consumers have shown a preference for high-potency, low-cost concentrates, creating high demand for inexpensive flower.

Demand for high-quality concentrates may increase as cannabis use continues to become more mainstream, though it’s unlikely to supplant low-cost, value-oriented concentrates in the near future.

While there may be an immediate opportunity for growers to specialize in and provide low-cost product if and when marijuana is legalized at the federal level, all but the largest and most efficient cultivators ultimately may be squeezed out of the market for value cannabis.

If large-scale retailers, such as big-box and grocery stores, eventually are able to sell cannabis, these outlets likely will offer prices that small-scale producers cannot match.

However, experienced marijuana business owners caution that as cannabis becomes a commodity, the value of a company is more dependent upon brand reputation and products lineup than price.

Value-added cultivation – such as sustainable and organic production – could emerge as a key segment similar to the food industry.

That creates a proverbial tightrope for cultivators to walk: They need to understand that meeting the current needs of the market for low-cost cannabis could come at a huge price if a major shake-up – such as federal legalization – occurs.

 

Disclaimer

Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.


Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.


DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.


Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.


Investment Value Finders is intended for those 21+ years of age only!

Check Also

Aura Health Inc. is pleased to provide an operational update on Pharmadrug Production GmbH

Aura Health Inc. is pleased to provide an operational update on Pharmadrug Production GmbH

TORONTO, Aug. 13, 2019 (GLOBE NEWSWIRE) — Aura Health Inc. (the “Company” or “Aura”) (CSE:BUZZ, OTCQB:LMLLF) is …